Abstract
The immunosuppressant cyclosporin A inhibits transcription mediated by the nuclear factor of activated T-cells (NFAT), a key regulator of cytokine gene expression in lymphocytes that integrates phospholipase C signaling. NFAT is also expressed in vascular smooth muscle cells, but the genes it regulates there are unknown. Here we show that Gαq-coupled P2Y nucleotide receptor signaling in rat vascular smooth muscle cells increases NFAT-mediated luciferase reporter expression. It also induces interleukin (IL)-6 gene expression but not other cytokine mRNAs including IL-1, IL-2, IL-3, IL-4, IL-10, γ-interferon, tumor necrosis factor-α, or tumor necrosis factor-β. IL-6 mRNA induction by UTP is more rapid and transient then that caused by IL-1β stimulation and is partially blocked by cyclosporin A or by expression of atrans-dominant NFAT inhibitor. Expression of recombinant NFATc1 markedly augments IL-6 mRNA induction by these and other agonists, which is partially attributable to NFAT-regulated paracrine mediators. However, trans-dominant NFκB inhibitors strongly interfere with IL-6 mRNA induction both by IL-1β and by UTP, which synergistically evoke IL-6 mRNA expression. These findings suggest that NFAT is among the cofactors involved in NFκB-dependent IL-6 gene induction by Ca2+-mobilizing receptors in vascular smooth muscle cells.
Footnotes
- Received February 17, 1999.
- Accepted August 9, 2000.
-
Send reprint requests to: T. J. Murphy Ph.D., Department of Pharmacology, Emory University School of Medicine, 5031 O.W. Rollins Research Building, Atlanta, GA 30322. E-mail:medtjm{at}emory.edu
-
Supported by Grants HL52810 and HL56107 from the National Heart, Lung, and Blood Institute. T.J.M. is an Established Investigator of the American Heart Association. A.M.R. is supported by a National Institutes of Health predoctoral training grant (GM08602).
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|